Skip to main content
. 2018 Jun 27;4:92. doi: 10.1186/s40814-018-0285-5

Fig. 9.

Fig. 9

Study flowchart. Note: two participants withdrew after randomization and baseline due to transportation issues and delays in treatment. Inline graphicPeriod of time in which both the CBCS-HCV and SC groups received HCV treatment. Inline graphic Period of time in which only the CBCS-HCV received the CBCS intervention. Inline graphic Intervention group. Inline graphic Standard of care group. Inline graphic Measurement time points